Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1959 1
1961 2
1963 4
1964 2
1965 3
1967 1
1968 3
1969 3
1970 2
1971 1
1973 1
1974 2
1975 2
1976 3
1977 7
1978 10
1979 6
1980 2
1981 9
1982 3
1984 3
1985 2
1986 3
1987 2
1989 3
1990 2
1991 6
1992 4
1993 9
1994 10
1995 6
1996 13
1997 17
1998 13
1999 17
2000 25
2001 17
2002 23
2003 40
2004 46
2005 54
2006 58
2007 53
2008 68
2009 104
2010 116
2011 109
2012 114
2013 118
2014 154
2015 183
2016 222
2017 233
2018 285
2019 332
2020 398
2021 525
2022 564
2023 67
Text availability
Article attribute
Article type
Publication date

Search Results

3,660 results
Results by year
Filters applied: . Clear all
Page 1
Debate on mandatory COVID-19 vaccination.
Cheng FK. Cheng FK. Ethics Med Public Health. 2022 Apr;21:100761. doi: 10.1016/j.jemep.2022.100761. Epub 2022 Jan 24. Ethics Med Public Health. 2022. PMID: 35097181 Free PMC article.
Molecular Subgroups of Intrahepatic Cholangiocarcinoma Discovered by Single-Cell RNA Sequencing-Assisted Multiomics Analysis.
Bao X, Li Q, Chen J, Chen D, Ye C, Dai X, Wang Y, Li X, Rong X, Cheng F, Jiang M, Zhu Z, Ding Y, Sun R, Liu C, Huang L, Jin Y, Li B, Lu J, Wu W, Guo Y, Fu W, Langley SR, Tano V, Fang W, Guo T, Sheng J, Zhao P, Ruan J. Bao X, et al. Among authors: cheng f. Cancer Immunol Res. 2022 Jul 1;10(7):811-828. doi: 10.1158/2326-6066.CIR-21-1101. Cancer Immunol Res. 2022. PMID: 35604302
Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial.
Xia Y, Tang W, Qian X, Li X, Cheng F, Wang K, Zhang F, Zhang C, Li D, Song J, Zhang H, Zhao J, Yao A, Wu X, Wu C, Ji G, Liu X, Zhu F, Qin L, Xiao X, Deng Z, Kong X, Li S, Yu Y, Xi W, Deng W, Qi C, Liu H, Pu L, Wang P, Wang X. Xia Y, et al. Among authors: cheng f. J Immunother Cancer. 2022 Apr;10(4):e004656. doi: 10.1136/jitc-2022-004656. J Immunother Cancer. 2022. PMID: 35379737 Free PMC article. Clinical Trial.
COVID-19 pandemic after Omicron.
Lai CKC, Lam W, Tsang KY, Cheng FWT, Wong MCS. Lai CKC, et al. Among authors: cheng fwt. Hong Kong Med J. 2022 Jun;28(3):196-198. doi: 10.12809/hkmj215130. Hong Kong Med J. 2022. PMID: 35765729 Free article. No abstract available.
3,660 results